Yeming Wang
7Patents
1h-index
25Co-inventors
51Inventor score
Filing activity: Feb 3, 2000 → May 27, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6605565B1 | Nanocrystal cerium zirconium composite oxide, its preparation and application | Emerging Cross-Sectional Technologies | 14 | Expired |
| US11414444B2 | P2X3 and/or P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereof | Chemistry; Metallurgy | 1 | Active |
| US11453690B2 | Receptor inhibitor, pharmaceutical composition comprising same, and use thereof | Chemistry; Metallurgy | 1 | Active |
| US12180243B2 | Receptor inhibitor, pharmaceutical composition comprising same, and use thereof | Chemistry; Metallurgy | 1 | Active |
| US11905274B2 | Receptor inhibitors, pharmaceutical compositions comprising the same and use thereof | Chemistry; Metallurgy | 0 | Active |
| US11919918B2 | P2X3 andor P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereof | Chemistry; Metallurgy | 0 | Active |
| US12410192B2 | Compound for inhibiting and inducing degradation of EGFR kinase | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.